Fludrocortisone

Fludrocortisone is a synthetic steroid hormone that belongs to the corticosteroid family ^[1]. Structurally it is a modified form of cortisol, the body's own stress hormone, made by adding a single fluorine atom at a specific position on the steroid skeleton, which greatly amplifies its salt-retaining action ^[1]. It is a very potent mineralocorticoid, hundreds of times stronger than cortisol at retaining sodium, while keeping only relatively modest glucocorticoid activity ^[1]. The compound is usually supplied as fludrocortisone acetate, an inactive ester that the body converts into fludrocortisone after it is absorbed ^[1].

The drug occupies a notable position in the history of medicine ^[1]. Described in the scientific literature in 1953 and introduced into clinical use in the following year, it was the first synthetic corticosteroid to be brought to market and also the first fluorine-containing pharmaceutical to be sold ^[1]. It has remained in continuous use ever since, is marketed under the brand name Florinef among others, and is listed among the World Health Organization's essential medicines ^[1].

Fludrocortisone is used chiefly to supply the salt-retaining hormone activity that patients lack when their adrenal glands fail ^[2][3]. In primary adrenal insufficiency, also known as Addison's disease, professional guidelines recommend it alongside a glucocorticoid such as hydrocortisone to replace both of the missing adrenal hormones ^[3]. It is likewise a standard part of treatment for the salt-wasting form of congenital adrenal hyperplasia caused by 21-hydroxylase deficiency ^[1]. Beyond hormone replacement, it is used off its original purpose to raise blood pressure in people who faint or feel lightheaded on standing, as in orthostatic hypotension and related conditions, and a test using the drug can help diagnose certain causes of high aldosterone ^[1].

Because its main action is to make the body retain sodium and water while shedding potassium, the predictable side effects of fludrocortisone are largely extensions of that effect ^[1]. These can include raised blood pressure, fluid retention and swelling, and low blood potassium, which may cause muscle weakness ^[1]. As with corticosteroids generally, higher or prolonged exposure can bring additional problems such as bone thinning, and doses in adrenal insufficiency are adjusted carefully using blood pressure, symptoms, and laboratory measures as a guide ^[3]. It is available as oral tablets ^[1].

Fludrocortisone is prescription only and its effects are dose sensitive. Because it makes the body hold salt and water, too much can cause high blood pressure, swelling, headache, and heart failure symptoms, while its potassium wasting can lead to low potassium and muscle weakness. When lying flat, some people get supine hypertension. It needs careful monitoring of blood pressure, potassium, and signs of fluid overload. In adrenal insufficiency it is used together with a glucocorticoid such as hydrocortisone, and the dose is adjusted using blood pressure, electrolytes, and a hormone called renin as a guide. Drugs that lower potassium or raise blood pressure can compound its effects.

Fludrocortisone exhibits a significant synergistic interaction with black licorice consumption, which can precipitate severe hypokalemia ^[4]. This is a pharmacodynamic interaction; both fludrocortisone (a mineralocorticoid) and black licorice metabolites induce apparent mineralocorticoid excess through increased sodium retention and potassium wasting, creating a compounding electrolyte disturbance that can be life-threatening ^[4]. Documented case reports show that patients consuming large quantities of licorice alongside fludrocortisone have presented with potassium levels as low as 2.4 mmol/L despite standard electrolyte monitoring ^[4]. Interactions with potassium-sparing diuretics and ACE inhibitors have been clinically inferred but lack prospective documentation; documented drug interactions beyond the licorice case are sparse in the medical literature.

Checking a whole stack? Run it through interactions + stacks.

Fludrocortisone holds a notable place in pharmaceutical history as the first fluorinated steroid drug ever brought to market. It was synthesised in the mid-1950s by Josef Fried and Emily Sabo at the Squibb Institute for Medical Research, who discovered that introducing a fluorine atom at the 9-alpha position of the cortisol molecule dramatically amplified its hormonal potency. This observation proved to be a landmark in steroid chemistry, for the same 9-alpha-fluoro strategy was soon used to create a whole generation of potent synthetic corticosteroids, including dexamethasone and betamethasone.

Marketed as the acetate ester under the brand name Florinef, fludrocortisone found its lasting role not as an anti-inflammatory but as a mineralocorticoid replacement, exploiting the strong salt-retaining activity that the fluorine modification conferred. It remains the standard agent for this purpose today and appears on the World Health Organization's List of Essential Medicines.

Among endocrinologists, fludrocortisone is regarded as the gold-standard mineralocorticoid replacement, valued because no other oral drug so reliably reproduces the salt-conserving action of aldosterone. In Addison's disease and the salt-wasting form of congenital adrenal hyperplasia it is considered essentially irreplaceable, and it has earned a devoted following in the management of orthostatic hypotension and related dysautonomias, where its ability to expand blood volume can markedly improve standing tolerance.

Its long clinical track record, low cost, and once-daily dosing add to its appeal. Physicians are candid, however, about the need for careful monitoring: because its whole purpose is to retain sodium and excrete potassium, treatment must be balanced against the risks of high blood pressure, fluid overload, and low potassium. Used thoughtfully and at the low doses typical of replacement therapy, it is a dependable and well understood medicine.